Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
1.030
-0.030 (-2.83%)
Jun 26, 2025, 4:00 PM - Market closed
Can-Fite BioPharma Stock Forecast
CANF's stock price has decreased by -63.73% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Can-Fite BioPharma stock have a consensus rating of "Strong Buy" and an average price target of $14, which forecasts a 1259.22% increase in the stock price over the next year. The lowest target is $10 and the highest is $18.
Price Target: $14 (+1259.22%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 15, 2025.
Analyst Ratings
The average analyst rating for Can-Fite BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +870.87% | Apr 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +870.87% | Mar 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +870.87% | Mar 20, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +870.87% | Mar 18, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +870.87% | Mar 3, 2025 |
Financial Forecast
Revenue This Year
3.79M
from 674.00K
Increased by 461.72%
Revenue Next Year
3.00M
from 3.79M
Decreased by -20.66%
EPS This Year
-4.20
from -0.00
EPS Next Year
1.29
from -4.20
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.9M | 3.1M | 109.2M |
| Avg | 3.8M | 3.0M | 106.1M |
| Low | 3.6M | 2.9M | 101.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 478.2% | -18.3% | 3,535.2% |
| Avg | 461.7% | -20.7% | 3,431.3% |
| Low | 439.6% | -23.8% | 3,292.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -4.33 | 1.32 |
| Avg | -4.20 | 1.29 |
| Low | -4.04 | 1.23 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.